Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 May;117(5):1114-1121.
doi: 10.1097/AOG.0b013e3182165ee8.

Lactogenesis after early postpartum use of the contraceptive implant: a randomized controlled trial

Shawn E Gurtcheff  1 , David K Turok, Greg Stoddard, Patricia A Murphy, Mark Gibson, Kirtly P Jones
Affiliations
Randomized Controlled Trial

Lactogenesis after early postpartum use of the contraceptive implant: a randomized controlled trial

Shawn E Gurtcheff et al. Obstet Gynecol. 2011 May.

Abstract

Objective: To evaluate lactogenesis after early postpartum insertion of the etonogestrel contraceptive implant.

Methods: Healthy peripartum women with healthy, term newborns who desired the etonogestrel implant for contraception were randomly assigned to early (1-3 days) or standard (4-8 weeks) postpartum insertion. The primary outcomes, time to lactogenesis stage II and lactation failure, were documented by a validated measure. The noninferiority margin for the mean difference in time to lactogenesis stage II was defined as 8 additional hours. Secondary data (device continuation and contraceptive use, breast milk analysis, supplementation rates, side effects, and bleeding patterns) were collected at periodic intervals for 6 months.

Results: Sixty-nine women were enrolled. Thirty-five were randomly assigned to early insertion and 34 to standard insertion. There were no statistically significant differences between the groups in age, race, parity, mode of delivery, use of anesthesia, or prior breastfeeding experience. Early insertion was demonstrated to be noninferior to standard insertion in time to lactogenesis stage II (early: [mean±standard deviation] 64.3±19.6 hours; standard: 65.2±18.5 hours, mean difference, -1.4 hours, 95% confidence interval [CI] -10.6 to 7.7 hours). Early insertion was also demonstrated to be noninferior to standard insertion in incidence of lactation failure (1/34 [3%] in the early insertion group, 0/35 [0%] in the standard insertion group [risk difference, 0.03, 95% CI -0.02 to 0.08]). Use of formula supplementation was not significantly different between the groups. Milk composition at 6 weeks was not significantly different between the groups.

Conclusion: Breastfeeding outcomes were similar in women who underwent early compared with standard postpartum insertion of the etonogestrel implant.

Clinical trial registration: ClinicalTrials.gov, www.clinicaltrials.gov, NCT00847587.

PubMed Disclaimer

Comment in

References

    1. Zhu BP, Rolfs RT, Nangle BE, Horan JM. Effect of the interval between pregnancies on perinatal outcomes. N Engl J Med 1999;340:589–94.
    1. Conde-Agudelo A, Rosas-Bermudez A, Kafury-Goeta AC. Effects of birth spacing on maternal health: a systematic review. Am J Obstet Gynecol 2007;196:297–308.
    1. Centers for Disease Control (CDC). Postpartum care visits–11 states and New York City, 2004. MMWR Morb Mortal Wkly Rep 2007;56:1312–6.
    1. Ogburn JA, Espey E, Stonehocker J. Barriers to intrauterine device insertion in postpartum women. Contraception 2005;72:426–9.
    1. Echeverry G. Family planning in the immediate postpartum period. Stud Fam Plann 1973;4:33–5.

Publication types

Associated data

LinkOut - more resources